Results 151 to 160 of about 63,869 (217)
Clomiphene Citrate and Pregnancy Outcome
Australian and New Zealand Journal of Obstetrics and Gynaecology, 1994 Summary: Data from Australia and elsewhere have shown consistently that adverse perinatal outcomes such as preterm birth and perinatal mortality are more common in pregnancies resulting from assisted conception with IVF and GIFT than normally conceived pregnancies.
A, Venn, J, Lumley
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Fertility and Sterility, 1977
Two hundred and fifty-five women received clomiphene citrate during a 10-year period. Fifty-six were treated diagnostically and one hundred and ninty-nine therapeutically for infertility. It is concluded that clomiphene may aid in confirming the diagnosis and establishing a prognosis in patients with primary or secondary amenorrhea.
J, Garcia, G S, Jones, A C, Wentz
openaire +2 more sources
Two hundred and fifty-five women received clomiphene citrate during a 10-year period. Fifty-six were treated diagnostically and one hundred and ninty-nine therapeutically for infertility. It is concluded that clomiphene may aid in confirming the diagnosis and establishing a prognosis in patients with primary or secondary amenorrhea.
J, Garcia, G S, Jones, A C, Wentz
openaire +2 more sources
The effects of clomiphene citrate on the endometrium
American Journal of Obstetrics and Gynecology, 1965Abstract Our experience with clomiphene citrate has been presented. Four categories of patients were investigated. The results with the patients in Groups I and II show that this drug is a promising one for the induction of ovulation. In patients with postmenopausal endometrial hyperplasia, some regression can be anticipated. The role of this drug in
J A, Wall +3 more
openaire +2 more sources
Effect of clomiphene citrate on oligospermia
American Journal of Obstetrics and Gynecology, 1967Abstract Clomiphene is thought to have an antiestrogenic effect and to enhance the release of gonadotropins from the pituitary. For these reasons, it was administered to 15 oligospermic infertile males that exhibited varying testicular derangements on biopsy to correlate any response with a particular histologic picture.
A, Mroueh, B, Lytton, N, Kase
openaire +2 more sources
Evaluation of the genotoxicity of clomiphene citrate
Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2014Clomiphene citrate (CC) is a selective estrogen-receptor modulator that is primarily used to enhance follicular development in women receiving in vitro fertilization (IVF) treatment. Although some studies suggested large increases in ovarian cancer risk related to fertility medications, this association has not been confirmed in other studies.
YILMAZ, SERKAN +4 more
openaire +3 more sources
Clomiphene Citrate for the Treatment of Hypogonadism
Sexual Medicine Reviews, 2019Clomiphene citrate (CC) is a selective estrogen receptor modulator that has been used for the treatment of hypogonadism in men since the 1970s. It acts centrally to increase secretion of luteinizing hormone and follicle-stimulating hormone, thereby increasing testosterone production and serum levels. Unlike testosterone replacement therapy, CC does not
Karen M, Wheeler +4 more
openaire +2 more sources